A perspective on new beta-lactam antibiotics in pediatric patients.
作者信息
Nelson J D
出版信息
Bull N Y Acad Med. 1984 May;60(4):374-9.
Abstract
摘要
相似文献
1
A perspective on new beta-lactam antibiotics in pediatric patients.
Bull N Y Acad Med. 1984 May;60(4):374-9.
2
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Adv Pediatr Infect Dis. 1996;12:71-108.
3
[Prospects of antibiotic treatment in pediatric field].
Nihon Rinsho. 1981 Jan;39(1):72-9.
4
Practical use of penicillin, cephalosporin and aminoglycoside antibiotics.
Calif Med. 1972 Oct;117(4):17-27.
5
Antibacterial agents in pediatrics.
Infect Dis Clin North Am. 1995 Sep;9(3):561-74.
6
[Antibiotics used for infections of central nervous system (suthor's transl)].
No Shinkei Geka. 1977 Aug;5(9):909-18.
7
[Clinical experience with azlocillin].
Med Welt. 1979 Nov 23;30(47):1790-3.
8
The new cephalosporins and penicillins.
Compr Ther. 1982 Feb;8(2):26-31.
9
American Academy of Pediatrics Committee on Infectious Diseases: Treatment of bacterial meningitis.
Pediatrics. 1988 Jun;81(6):904-7.
10
Guidelines issued on treatment of pediatric bacterial meningitis.
Clin Pharm. 1988 Sep;7(9):638.
本文引用的文献
1
Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.
Antimicrob Agents Chemother. 1981 Sep;20(3):281-5. doi: 10.1128/AAC.20.3.281.
2
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
J Pediatr. 1981 Jan;98(1):129-36. doi: 10.1016/s0022-3476(81)80559-8.
3
Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
J Infect Dis. 1983 Mar;147(3):559-67. doi: 10.1093/infdis/147.3.559.
4
Ceftriaxone pharmacokinetics in newborn infants.
Antimicrob Agents Chemother. 1983 Feb;23(2):341-3. doi: 10.1128/AAC.23.2.341.
5
Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
Antimicrob Agents Chemother. 1983 Feb;23(2):191-4. doi: 10.1128/AAC.23.2.191.
6
Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections.
J Pediatr. 1983 Jan;102(1):134-7. doi: 10.1016/s0022-3476(83)80311-4.
7
Pharmacokinetics of cefotaxime in newborn infants.
Antimicrob Agents Chemother. 1982 Apr;21(4):683-4. doi: 10.1128/AAC.21.4.683.
8
Clinical pharmacology of cefotaxime in pediatric patients.
Antimicrob Agents Chemother. 1981 Oct;20(4):487-90. doi: 10.1128/AAC.20.4.487.
9
Single-dose pharmacokinetics of ceftriaxone in infants and young children.
Antimicrob Agents Chemother. 1982 Feb;21(2):248-53. doi: 10.1128/AAC.21.2.248.
10
Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.
J Pediatr. 1982 Mar;100(3):483-9. doi: 10.1016/s0022-3476(82)80466-6.
Zotero 插件